Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis.
Yusuke SatoSatoru MotoyamaYuki WadaAkiyuki WakitaYuta KawakitaYushi NagakiKaori TerataKazuhiro ImaiAkira AnbaiManabu HashimotoYoshihiro MinamiyaPublished in: Cancers (2021)
NACRT followed by esophagectomy with three-field LN dissection is feasible and offers the potential for long-term survival of clinical Stage III ESCC patients and even clinical Stage IVB patients with supraclavicular LN metastasis as the only distant metastatic factor. At least in patients with upper and middle thoracic ESCC, treating supraclavicular LNs as regional LNs seems to be appropriate.
Keyphrases
- lymph node metastasis
- rectal cancer
- squamous cell carcinoma
- lymph node
- end stage renal disease
- spinal cord
- small cell lung cancer
- locally advanced
- ejection fraction
- prostate cancer
- chronic kidney disease
- robot assisted
- radiation therapy
- peritoneal dialysis
- risk assessment
- prognostic factors
- climate change
- patient reported outcomes
- sentinel lymph node